“Imatinib treatment and pharmacogenotype CYP3A4 in relation with the clonal expansion Ph(+) in chronic myeloid leukemia (CML)”., Colomb Med, vol. 39, no. 4, pp. 314–322, Dec. 2008, doi: 10.25100/cm.v39i4.613.